CCM
CSII

CAAS Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

CAAS Capital Management’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-29,210
Closed -$922K – 645
2020
Q2 		$922K Buy
+29,210
New +$1.09M 0.03% 276

Other funds holding CSII

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

CAAS Capital Management's CSII Position: Q3 2020 in Review

CAAS Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2020, closing a stake of 29,210 shares — an estimated $922K sold.

CAAS Capital Management first reported a position in CSII in Q2 2020 and held it in 1 quarter. The position peaked at $922K in Q2 2020. 186 funds tracked by Wall St. Rank hold CSII as of Q3 2020.

  • CAAS Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q3 2020 after selling out during the quarter.
  • CAAS Capital Management sold 29,210 Cardiovascular Systems, Inc. shares in Q3 2020, an estimated $922K.
  • CAAS Capital Management first reported a position in Cardiovascular Systems, Inc. in Q2 2020 and held it in 1 quarter.
  • CAAS Capital Management's Cardiovascular Systems, Inc. position peaked at $922K in Q2 2020.
  • 186 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2020.

Based on CAAS Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.